Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 190

1.

Posttranscriptional regulation of UGT2B10 hepatic expression and activity by alternative splicing.

Labriet A, Allain EP, Rouleau M, Audet-Delage Y, Villeneuve L, Guillemette C.

Drug Metab Dispos. 2018 Feb 9. pii: dmd.117.079921. doi: 10.1124/dmd.117.079921. [Epub ahead of print]

PMID:
29438977
2.

Peritoneal Carcinomatosis of Urachus Origin Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): An International Registry of 36 Patients.

Mercier F, Passot G, Villeneuve L, Levine EA, Yonemura Y, Goéré D, Sugarbaker PH, Marolho C, Bartlett DL, Glehen O; BIG-RENAPE Working Group.

Ann Surg Oncol. 2017 Dec 13. doi: 10.1245/s10434-017-6299-z. [Epub ahead of print]

PMID:
29238881
3.

Estradiol metabolites as biomarkers of endometrial cancer prognosis after surgery.

Audet-Delage Y, Grégoire J, Caron P, Turcotte V, Plante M, Ayotte P, Simonyan D, Villeneuve L, Guillemette C.

J Steroid Biochem Mol Biol. 2017 Oct 29. pii: S0960-0760(17)30318-7. doi: 10.1016/j.jsbmb.2017.10.021. [Epub ahead of print]

PMID:
29092787
4.

Improved Progression-Free Survival in Irinotecan-Treated Metastatic Colorectal Cancer Patients Carrying the HNF1A Coding Variant p.I27L.

Labriet A, De Mattia E, Cecchin E, Lévesque É, Jonker D, Couture F, Buonadonna A, D'Andrea M, Villeneuve L, Toffoli G, Guillemette C.

Front Pharmacol. 2017 Oct 10;8:712. doi: 10.3389/fphar.2017.00712. eCollection 2017.

5.

Characterization of a Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Model for the Study of Variant Pathogenicity: Validation of a KCNJ2 Mutation.

Gélinas R, El Khoury N, Chaix MA, Beauchamp C, Alikashani A, Ethier N, Boucher G, Villeneuve L, Robb L, Latour F, Mondesert B, Rivard L, Goyette P, Talajic M, Fiset C, Rioux JD.

Circ Cardiovasc Genet. 2017 Oct;10(5). pii: e001755. doi: 10.1161/CIRCGENETICS.117.001755.

PMID:
29021306
6.

Multicentric initial experience with the use of the pressurized intraperitoneal aerosol chemotherapy (PIPAC) in the management of unresectable peritoneal carcinomatosis.

Alyami M, Gagniere J, Sgarbura O, Cabelguenne D, Villeneuve L, Pezet D, Quenet F, Glehen O, Bakrin N, Passot G.

Eur J Surg Oncol. 2017 Nov;43(11):2178-2183. doi: 10.1016/j.ejso.2017.09.010. Epub 2017 Sep 21.

PMID:
28964609
7.

Ninety-day post-operative morbidity and mortality using the National Cancer Institute's common terminology criteria for adverse events better describe post-operative outcome after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Alyami M, Kim BJ, Villeneuve L, Vaudoyer D, Képénékian V, Bakrin N, Gilly FN, Cotte E, Glehen O, Passot G.

Int J Hyperthermia. 2017 Aug 24:1-6. doi: 10.1080/02656736.2017.1367846. [Epub ahead of print]

PMID:
28838265
8.

Nestin expression is dynamically regulated in cardiomyocytes during embryogenesis.

Hertig V, Matos-Nieves A, Garg V, Villeneuve L, Mamarbachi M, Caland L, Calderone A.

J Cell Physiol. 2018 Apr;233(4):3218-3229. doi: 10.1002/jcp.26165. Epub 2017 Sep 27.

PMID:
28834610
9.

Immunohistochemical evaluation of two antibodies against PD-L1 and prognostic significance of PD-L1 expression in epithelioid peritoneal malignant mesothelioma: A RENAPE study.

Valmary-Degano S, Colpart P, Villeneuve L, Monnien F, M'Hamdi L, Lang Averous G, Capovilla M, Bibeau F, Laverriere MH, Verriele-Beurrier V, Ben Rejeb H, Dartigues P, Hommell-Fontaine J, Gilly FN, Isaac S, Mery E; French RENAPE Network.

Eur J Surg Oncol. 2017 Oct;43(10):1915-1923. doi: 10.1016/j.ejso.2017.05.009. Epub 2017 May 18.

PMID:
28619621
10.

Nestin expression is upregulated in the fibrotic rat heart and is localized in collagen-expressing mesenchymal cells and interstitial CD31(+)- cells.

Hertig V, Tardif K, Meus MA, Duquette N, Villeneuve L, Toussaint F, Ledoux J, Calderone A.

PLoS One. 2017 Apr 27;12(4):e0176147. doi: 10.1371/journal.pone.0176147. eCollection 2017.

11.

Quantitative profiling of the UGT transcriptome in human drug-metabolizing tissues.

Tourancheau A, Rouleau M, Guauque-Olarte S, Villeneuve L, Gilbert I, Droit A, Guillemette C.

Pharmacogenomics J. 2017 Apr 25. doi: 10.1038/tpj.2017.5. [Epub ahead of print]

12.

The RENAPE observational registry: rationale and framework of the rare peritoneal tumors French patient registry.

Villeneuve L, Passot G, Glehen O, Isaac S, Bibeau F, Rousset P, Gilly FN; RENAPE Network.

Orphanet J Rare Dis. 2017 Feb 17;12(1):37. doi: 10.1186/s13023-017-0571-y.

13.

Development of a new bioactivatable fluorescent probe for quantification of apolipoprotein A-I proteolytic degradation in vitro and in vivo.

Maafi F, Li B, Gebhard C, Brodeur MR, Nachar W, Villeneuve L, Lesage F, Rhainds D, Rhéaume E, Tardif JC.

Atherosclerosis. 2017 Mar;258:8-19. doi: 10.1016/j.atherosclerosis.2017.01.026. Epub 2017 Jan 21.

PMID:
28167355
14.

Age Nutrition Chirugie (ANC) study: impact of a geriatric intervention on the screening and management of undernutrition in elderly patients operated on for colon cancer, a stepped wedge controlled trial.

Dupuis M, Kuczewski E, Villeneuve L, Bin-Dorel S, Haine M, Falandry C, Gilbert T, Passot G, Glehen O, Bonnefoy M.

BMC Geriatr. 2017 Jan 7;17(1):10. doi: 10.1186/s12877-016-0402-3.

15.

BAP1 Is Altered by Copy Number Loss, Mutation, and/or Loss of Protein Expression in More Than 70% of Malignant Peritoneal Mesotheliomas.

Leblay N, Leprêtre F, Le Stang N, Gautier-Stein A, Villeneuve L, Isaac S, Maillet D, Galateau-Sallé F, Villenet C, Sebda S, Goracci A, Byrnes G, McKay JD, Figeac M, Glehen O, Gilly FN, Foll M, Fernandez-Cuesta L, Brevet M.

J Thorac Oncol. 2017 Apr;12(4):724-733. doi: 10.1016/j.jtho.2016.12.019. Epub 2016 Dec 27.

PMID:
28034829
16.

A Rare UGT2B7 Variant Creates a Novel N-Glycosylation Site at Codon 121 with Impaired Enzyme Activity.

Girard-Bock C, Benoit-Biancamano MO, Villeneuve L, Desjardins S, Guillemette C.

Drug Metab Dispos. 2016 Dec;44(12):1867-1871. Epub 2016 Sep 9.

17.

A Perioperative Clinical Pathway Can Dramatically Reduce Failure-to-rescue Rates After Cytoreductive Surgery for Peritoneal Carcinomatosis: A Retrospective Study of 666 Consecutive Cytoreductions.

Passot G, Vaudoyer D, Villeneuve L, Wallet F, Beaujard AC, Boschetti G, Rousset P, Bakrin N, Cotte E, Glehen O.

Ann Surg. 2017 Apr;265(4):806-813. doi: 10.1097/SLA.0000000000001723.

PMID:
27775553
18.

SWATH-MS proteome profiling data comparison of DJ-1, Parkin, and PINK1 knockout rat striatal mitochondria.

Stauch KL, Villeneuve LM, Purnell PR, Pandey S, Guda C, Fox HS.

Data Brief. 2016 Sep 23;9:589-593. eCollection 2016 Dec.

19.

Divergent Expression and Metabolic Functions of Human Glucuronosyltransferases through Alternative Splicing.

Rouleau M, Tourancheau A, Girard-Bock C, Villeneuve L, Vaucher J, Duperré AM, Audet-Delage Y, Gilbert I, Popa I, Droit A, Guillemette C.

Cell Rep. 2016 Sep 27;17(1):114-124. doi: 10.1016/j.celrep.2016.08.077.

20.

Loss of Pink1 modulates synaptic mitochondrial bioenergetics in the rat striatum prior to motor symptoms: concomitant complex I respiratory defects and increased complex II-mediated respiration.

Stauch KL, Villeneuve LM, Purnell PR, Ottemann BM, Emanuel K, Fox HS.

Proteomics Clin Appl. 2016 Dec;10(12):1205-1217. doi: 10.1002/prca.201600005. Epub 2016 Sep 21.

21.

Nestin Expressed by Pre-Existing Cardiomyocytes Recapitulated in Part an Embryonic Phenotype; Suppressive Role of p38 MAPK.

Meus MA, Hertig V, Villeneuve L, Jasmin JF, Calderone A.

J Cell Physiol. 2017 Jul;232(7):1717-1727. doi: 10.1002/jcp.25496. Epub 2016 Jul 27.

PMID:
27439108
22.

Trafficking Dynamics of PCSK9-Induced LDLR Degradation: Focus on Human PCSK9 Mutations and C-Terminal Domain.

Poirier S, Hamouda HA, Villeneuve L, Demers A, Mayer G.

PLoS One. 2016 Jun 9;11(6):e0157230. doi: 10.1371/journal.pone.0157230. eCollection 2016.

23.

Genomic copy number alterations in 33 malignant peritoneal mesothelioma analyzed by comparative genomic hybridization array.

Chirac P, Maillet D, Leprêtre F, Isaac S, Glehen O, Figeac M, Villeneuve L, Péron J, Gibson F, Galateau-Sallé F, Gilly FN, Brevet M.

Hum Pathol. 2016 Sep;55:72-82. doi: 10.1016/j.humpath.2016.04.015. Epub 2016 May 14.

PMID:
27184482
24.

What made hyperthermic intraperitoneal chemotherapy an effective curative treatment for peritoneal surface malignancy: A 25-year experience with 1,125 procedures.

Passot G, Vaudoyer D, Villeneuve L, Kepenekian V, Beaujard AC, Bakrin N, Cotte E, Gilly FN, Glehen O.

J Surg Oncol. 2016 Jun;113(7):796-803. doi: 10.1002/jso.24248. Epub 2016 Apr 25.

PMID:
27110915
25.

A new internet tool to report peritoneal malignancy extent. PeRitOneal MalIgnancy Stage Evaluation (PROMISE) application.

Villeneuve L, Thivolet A, Bakrin N, Mohamed F, Isaac S, Valette PJ, Glehen O, Rousset P; BIG-RENAPE and RENAPE Working Groups.

Eur J Surg Oncol. 2016 Jun;42(6):877-82. doi: 10.1016/j.ejso.2016.03.015. Epub 2016 Mar 28.

PMID:
27067193
26.

Definition of giant ventral hernias: Development of standardization through a practice survey.

Passot G, Villeneuve L, Sabbagh C, Renard Y, Regimbeau JM, Verhaeghe P, Kianmanesh R, Palot JP, Vaudoyer D, Glehen O, Cotte E; Fédération de Recherche en Chirurgie (FRENCH).

Int J Surg. 2016 Apr;28:136-40. doi: 10.1016/j.ijsu.2016.01.097. Epub 2016 Feb 13.

PMID:
26889971
27.

Neonatal mitochondrial abnormalities due to PINK1 deficiency: Proteomics reveals early changes relevant to Parkinson׳s disease.

Villeneuve LM, Purnell PR, Stauch KL, Fox HS.

Data Brief. 2015 Dec 17;6:428-32. doi: 10.1016/j.dib.2015.11.070. eCollection 2016 Mar.

28.

HIV-1 transgenic rats display mitochondrial abnormalities consistent with abnormal energy generation and distribution.

Villeneuve LM, Purnell PR, Stauch KL, Callen SE, Buch SJ, Fox HS.

J Neurovirol. 2016 Oct;22(5):564-574. Epub 2016 Feb 3.

29.

The Proteomic Characterization of Plasma or Serum from HIV-Infected Patients.

Haverland NA, Villeneuve LM, Ciborowski P, Fox HS.

Methods Mol Biol. 2016;1354:293-310. doi: 10.1007/978-1-4939-3046-3_20.

PMID:
26714720
30.

Endothelial and Epithelial Cell Transition to a Mesenchymal Phenotype Was Delineated by Nestin Expression.

Chabot A, Hertig V, Boscher E, Nguyen QT, Boivin B, Chebli J, Bissonnette L, Villeneuve L, Brochiero E, Dupuis J, Calderone A.

J Cell Physiol. 2016 Jul;231(7):1601-10. doi: 10.1002/jcp.25257. Epub 2015 Dec 2.

PMID:
26574905
31.

ABCC5 and ABCG1 polymorphisms predict irinotecan-induced severe toxicity in metastatic colorectal cancer patients.

Chen S, Villeneuve L, Jonker D, Couture F, Laverdière I, Cecchin E, Innocenti F, Toffoli G, Lévesque E, Guillemette C.

Pharmacogenet Genomics. 2015 Dec;25(12):573-83. doi: 10.1097/FPC.0000000000000168.

PMID:
26352872
32.

Professional risks when carrying out cytoreductive surgery for peritoneal malignancy with hyperthermic intraperitoneal chemotherapy (HIPEC): A French multicentric survey.

Ferron G, Simon L, Guyon F, Glehen O, Goere D, Elias D, Pocard M, Gladieff L, Bereder JM, Brigand C, Classe JM, Guilloit JM, Quenet F, Abboud K, Arvieux C, Bibeau F, De Chaisemartin C, Delroeux D, Durand-Fontanier S, Goasguen N, Gouthi L, Heyd B, Kianmanesh R, Leblanc E, Loi V, Lorimier G, Marchal F, Mariani P, Mariette C, Meeus P, Msika S, Ortega-Deballon P, Paineau J, Pezet D, Piessen G, Pirro N, Pomel C, Porcheron J, Pourcher G, Rat P, Regimbeau JM, Sabbagh C, Thibaudeau E, Torrent JJ, Tougeron D, Tuech JJ, Zinzindohoue F, Lundberg P, Herin F, Villeneuve L; BIG-RENAPE Working Group.

Eur J Surg Oncol. 2015 Oct;41(10):1361-7. doi: 10.1016/j.ejso.2015.07.012. Epub 2015 Jul 29.

PMID:
26263848
33.

Data for mitochondrial proteomic alterations in the aging mouse brain.

Stauch KL, Purnell PR, Villeneuve LM, Fox HS.

Data Brief. 2015 May 21;4:127-9. doi: 10.1016/j.dib.2015.05.004. eCollection 2015 Sep.

34.

Data for mitochondrial proteomic alterations in the developing rat brain.

Villeneuve LM, Stauch KL, Fox HS.

Data Brief. 2014 Aug 12;1:42-5. doi: 10.1016/j.dib.2014.07.002. eCollection 2014 Dec.

35.

The UGT2B28 Sex-steroid Inactivation Pathway Is a Regulator of Steroidogenesis and Modifies the Risk of Prostate Cancer Progression.

Belledant A, Hovington H, Garcia L, Caron P, Brisson H, Villeneuve L, Simonyan D, Têtu B, Fradet Y, Lacombe L, Guillemette C, Lévesque E.

Eur Urol. 2016 Apr;69(4):601-9. doi: 10.1016/j.eururo.2015.06.054. Epub 2015 Jul 26.

PMID:
26215610
36.

Caged ligands to study the role of intracellular GPCRs.

Tadevosyan A, Villeneuve LR, Fournier A, Chatenet D, Nattel S, Allen BG.

Methods. 2016 Jan 1;92:72-7. doi: 10.1016/j.ymeth.2015.07.005. Epub 2015 Jul 18.

PMID:
26196333
37.

Multiplexed Targeted Quantitative Proteomics Predicts Hepatic Glucuronidation Potential.

Margaillan G, Rouleau M, Klein K, Fallon JK, Caron P, Villeneuve L, Smith PC, Zanger UM, Guillemette C.

Drug Metab Dispos. 2015 Sep;43(9):1331-5. doi: 10.1124/dmd.115.065391. Epub 2015 Jun 15.

38.

Unravelling the transcriptomic landscape of the major phase II UDP-glucuronosyltransferase drug metabolizing pathway using targeted RNA sequencing.

Tourancheau A, Margaillan G, Rouleau M, Gilbert I, Villeneuve L, Lévesque E, Droit A, Guillemette C.

Pharmacogenomics J. 2016 Feb;16(1):60-70. doi: 10.1038/tpj.2015.20. Epub 2015 Apr 14.

39.

GRECCAR 8: impact on survival of the primary tumor resection in rectal cancer with unresectable synchronous metastasis: a randomized multicentre study.

Cotte E, Villeneuve L, Passot G, Boschetti G, Bin-Dorel S, Francois Y, Glehen O; French Research Group of Rectal Cancer Surgery (GRECCAR).

BMC Cancer. 2015 Feb 12;15:47. doi: 10.1186/s12885-015-1060-0.

40.

A novel UGT1 marker associated with better tolerance against irinotecan-induced severe neutropenia in metastatic colorectal cancer patients.

Chen S, Laverdiere I, Tourancheau A, Jonker D, Couture F, Cecchin E, Villeneuve L, Harvey M, Court MH, Innocenti F, Toffoli G, Lévesque E, Guillemette C.

Pharmacogenomics J. 2015 Dec;15(6):513-20. doi: 10.1038/tpj.2015.12. Epub 2015 Mar 17.

PMID:
25778466
41.

Nestin upregulation characterizes vascular remodeling secondary to hypertension in the rat.

Tardif K, Hertig V, Duquette N, Villeneuve L, El-Hamamsy I, Tanguay JF, Calderone A.

Am J Physiol Heart Circ Physiol. 2015 May 15;308(10):H1265-74. doi: 10.1152/ajpheart.00804.2014. Epub 2015 Mar 13.

42.

Quantitative profiling of human renal UDP-glucuronosyltransferases and glucuronidation activity: a comparison of normal and tumoral kidney tissues.

Margaillan G, Rouleau M, Fallon JK, Caron P, Villeneuve L, Turcotte V, Smith PC, Joy MS, Guillemette C.

Drug Metab Dispos. 2015 Apr;43(4):611-9. doi: 10.1124/dmd.114.062877. Epub 2015 Feb 3.

43.

Proteomic analysis and functional characterization of mouse brain mitochondria during aging reveal alterations in energy metabolism.

Stauch KL, Purnell PR, Villeneuve LM, Fox HS.

Proteomics. 2015 May;15(9):1574-86. doi: 10.1002/pmic.201400277. Epub 2015 Feb 10.

44.

Photoreleasable ligands to study intracrine angiotensin II signalling.

Tadevosyan A, Létourneau M, Folch B, Doucet N, Villeneuve LR, Mamarbachi AM, Pétrin D, Hébert TE, Fournier A, Chatenet D, Allen BG, Nattel S.

J Physiol. 2015 Feb 1;593(3):521-39. doi: 10.1113/jphysiol.2014.279109. Epub 2015 Jan 7.

45.

Early Expression of Parkinson's Disease-Related Mitochondrial Abnormalities in PINK1 Knockout Rats.

Villeneuve LM, Purnell PR, Boska MD, Fox HS.

Mol Neurobiol. 2016 Jan;53(1):171-186. doi: 10.1007/s12035-014-8927-y. Epub 2014 Nov 25.

46.

Impact of neoadjuvant chemoradiotherapy on postoperative outcomes after esophageal cancer resection: results of a European multicenter study.

Gronnier C, Tréchot B, Duhamel A, Mabrut JY, Bail JP, Carrere N, Lefevre JH, Brigand C, Vaillant JC, Adham M, Msika S, Demartines N, El Nakadi I, Piessen G, Meunier B, Collet D, Mariette C; FREGAT Working Group-FRENCH-AFC, Luc G, Cabau M, Jougon J, Badic B, Lozach P, Cappeliez S, Lebreton G, Alves A, Flamein R, Pezet D, Pipitone F, Iuga BS, Contival N, Pappalardo E, Mantziari S, Hec F, Vanderbeken M, Tessier W, Briez N, Fredon F, Gainant A, Mathonnet M, Bigourdan JM, Mezoughi S, Ducerf C, Baulieux J, Pasquer A, Baraket O, Poncet G, Vaudoyer D, Enfer J, Villeneuve L, Glehen O, Coste T, Fabre JM, Marchal F, Frisoni R, Ayav A, Brunaud L, Bresler L, Cohen C, Aze O, Venissac N, Pop D, Mouroux J, Donici I, Prudhomme M, Felli E, Lisunfui S, Seman M, Petit GG, Karoui M, Tresallet C, Ménégaux F, Hannoun L, Malgras B, Lantuas D, Pautrat K, Pocard M, Valleur P.

Ann Surg. 2014 Nov;260(5):764-70; discussion 770-1. doi: 10.1097/SLA.0000000000000955.

PMID:
25379847
47.

Using caged ligands to study intracrine endothelin signaling in intact cardiac myocytes.

Merlen C, Villeneuve LR, Allen BG.

Methods Mol Biol. 2015;1234:31-41. doi: 10.1007/978-1-4939-1755-6_4.

PMID:
25304346
48.

Dyadic Adjustment Scale: a validation study among older French-Canadians living in relationships.

Villeneuve L, Trudel G, Préville M, Dargis L, Boyer R, Bégin J.

Can J Aging. 2015 Mar;34(1):26-35. doi: 10.1017/S0714980814000269. Epub 2014 Sep 23.

PMID:
25247256
49.

Nestin downregulation in rat vascular smooth muscle cells represents an early marker of vascular disease in experimental type I diabetes.

Tardif K, Hertig V, Dumais C, Villeneuve L, Perrault L, Tanguay JF, Calderone A.

Cardiovasc Diabetol. 2014 Aug 21;13:119. doi: 10.1186/s12933-014-0119-6.

50.

Proteomic analysis of the mitochondria from embryonic and postnatal rat brains reveals response to developmental changes in energy demands.

Villeneuve LM, Stauch KL, Fox HS.

J Proteomics. 2014 Sep 23;109:228-39. doi: 10.1016/j.jprot.2014.07.011. Epub 2014 Jul 18.

Supplemental Content

Loading ...
Support Center